13Th Meeting of Competent Authorities for REACH and CLP (CARACAL)

1 (33)

Helsinki, 12/11/2013

Doc. CA/46/2013

13th Meeting of Competent Authorities for REACH and CLP (CARACAL)

26 - 28November 2013

Centre A. Borschette, Room1D

Brussels, Belgium

Concerns:STATUS REPORT ON CLH DOSSIERS

Agenda Item:Information point 4

Action requested:For information

Status Report on Harmonised Classification and Labelling proposals (CLH Dossiers)

(on 31 October 2013)

1.Background

According to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (the “CLP Regulation”) Member State Competent Authorities (MSCAs) as well as Manufacturers, Importers and Downstream Users may submit proposals for the harmonised Classification & Labelling of chemicals (CLH dossiers) to ECHA.

The Status Report on CLH dossiers is given for information to enable the different parties involved to evaluate quantitatively and per substance type, the number of dossiers that have been and will be processed by MSCAs, ECHA Secretariat and RAC.

2.Overview ofCLHdossiers submitted to ECHA, processed and adopted by RAC

Table 1 below presents an overview of the annual and cumulative CLH dossiers submitted and processed by ECHA Secretariat and RAC since 2008. In total, 229 CLH dossiers have been submitted amongst which only four by Manufacturers, Importers or Downstream Users.

The figures show that the total number of CLH dossiers submitted is declining since 2011. The number of completed public consultations and opinions adopted by RAC per year reach a plateau at ~ 30/year.

Table 1. Annual and cumulative number of CLH Dossiers

Phase of the process / 2008 / 2009 / 2010 / 2011 / 2012 / 2013
(as of 31/10/2013) / Cumulative Total
CLH dossiers submitted to ECHA$ / 14 / 33 / 76 / 56 / 28 / 22 / 229
Public consultations
Completed+ / - / 12 / 30 / 35 / 30 / 35 / 142
Opinions
Adopted by RAC* / - / 1 / 16 / 32 / 31 / 25 / 105

$Includes (temporarily) withdrawn CLH dossiers (n=18) and CLH dossiers submitted by Industry (n=6)

* Trisodium hexafluoroaluminate (cryolite), natural and synthetic and 3 white spirit dossiers are counted separately

+Art.77 opinions not included

Figure 1 below presents the distribution (per MSCA) of CLH dossiers which have been submitted and processed by ECHA Secretariat & RAC since 2008.

Figure2 below presents the distribution of CLH dossiers per chemical type submitted and processed by ECHA Secretariat & RAC since 2008.

3.Overview ofCLHdossiers for 2014

According to our estimates, ECHA will receive more CLH dossiers in 2014 than in the past two years. ECHA is collaborating with EFSA to streamline the approval of new active substances (PPPs) under Regulation 1107/2009. Sulfoxaflor and flumioxazin are the first cases to go through RAC opinion development during EFSA peer review. ECHA is expecting to receive several CLH dossiers in 2014 for which no intentions have been submitted yet.

In addition, ECHA is planning to streamline the submission of CLH dossiers with Manufacturers, Importers and Downstream Users. The objective is to accelerate the harmonisation of substances registered under REACH which are of high concern.

Table 2. Expected CLH dossiers processed in 2014$

Intentions received / Potential new intentions+ / Resubmissions* / PC* / Opinion development* / RAC opinion
2014 / 18 / 25-40 / 50-80 / 50-70 / 50-70 / >40

$excluding new active substances to be aligned with EFSA

+based on ECHA survey with MSCAs

* including 25 Straight Chain Lepidopteran Pheromones (SCLPs) acetates and alcohols

4.Status Report as of 30 October 2013

The following annexes provide detailed information on CLH dossiers in various phases of the CLH process as of 30 October 2013. CLH dossiers before adoption by RAC have been ordered in Table 2a according to their status. Approximately half of the 117 CLH dossiers in the CLH process are awaiting resubmission by MSCAs.

• Annex I: Notifications of intention to submit CLH dossiers (MSCA)

-Table 1. Notifications of intention (n=36)

• Annex II: CLH dossiers in the CLH process (before RAC adoption)

-Table 2A. Dossiers in Accordance Check (n=8)

-Table 2B. Dossiers pending public consultation (n=63)

-Table 2C. Dossiers under public consultation (n=4)

-Table 2D. RAC Opinion Development (n=31)

• Annex III: Opinions adopted by RAC

-Table 3A. Opinions adopted by RAC (n=104 excl. cryolite)

-Table 3B. Adopted opinions on Art. 77(3)c requests under the REACH Regulation (n=5)

• Annex IV: CLH dossiers withdrawn

-Table 4. Withdrawn CLH dossiers (n=18)

1

Annex I: Notifications of intention to submit CLH dossiers (MSCA)

Table 1. Notifications of intentions

No / MS / Substance Name / EC number / CAS number / Notification date / (Expected) Date of Submission
1 / DE / tefluthrin (ISO); 2,3,5,6-tetrafluoro-4-methylbenzyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate / - / 79538-32-2 / 29/10/2013 / 29/11/2013
2 / DE / isobutyl methacrylate / 202-613-0 / 97-86-9 / 18/10/2013 / 28/11/2013
3 / FR / benzovindiflupyr (ISO); N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide / - / 1072957-71-1 / 17/10/2013 / 20/01/2014
4 / NO / pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one / - / 123312-89-0 / 01/10/2013 / 01/02/2014
5 / NO / dibutyltin dilaurate / 201-039-8 / 77-58-7 / 30/09/2013 / 01/07/2014
6 / SE / Cadmium carbonate / 208-168-9 / 513-78-0 / 27/09/2013 / 31/01/2014
7 / SE / cadmium dihydroxide / 244-168-5 / 21041-95-2 / 27/09/2013 / 31/01/2014
8 / SE / cadmium dinitrate / 233-710-6 / 10325-94-7 / 19/09/2013 / 20/12/2013
9 / DE / azadirachtin / - / 11141-17-6 / 07/08/2013 / 30/09/2013
10 / DE / margosa extract from the kernels of Azadirachta indica extracted with water and further processed with organic solvents / 283-644-7 / 84696-25-3 / 07/08/2013 / 30/09/2013
11 / NL / spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate / 148477-71-8 / 14/06/2013 / 01/11/2013
12 / NL / silicon dioxide[1] / 231-545-4 / 7631-86-9 / 01/03/2013 / 01/07/2013
13 / SE / n,n-diethyl-m-toluamide; deet / 205-149-7 / 134-62-3 / 14/01/2013 / 30/09/2013
14 / SI / 2-methylisothiazol-3(2H)-one / 220-239-6 / 2682-20-4 / 23/11/2012 / 31/12/2013
15 / UK / quizalofop-P-terfuryl; (RS)-Tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenoxy]propionate / 414-200-4 / 200509-41-7 / 07/06/2012 / 01/03/2014
16 / FI / hymexazol (ISO); 3-hydroxy-5-methylisoxazole / 233-000-6 / 10004-44-1 / 25/04/2012 / 31/12/2013
17 / FR / 4-Chloro-3-methylphenol / 200-431-6 / 59-50-7 / 09/03/2012 / Submission postponed
18 / FR / peroxyoctanoic acid / 450-280-7 / 33734-57-5 / 09/03/2012 / Submission postponed
19 / FR / mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one / - / 55965-84-9 / 09/03/2012 / Submission postponed
20 / SE / nonadecafluorodecanoic acid / 206-400-3 / 335-76-2 / 20/06/2013 / 31/12/2013
21 / NL / sodium hypochlorite / 231-668-3 / 7681-52-9 / 23/02/2012 / 01/07/2014
22 / UK / carboxin (5,6-dihydro-2-methyl-1,4-oxathiine-3-carboxanilide) / 226-031-1 / 5234-68-4 / 24/11/2011 / 15/01/2014
23 / UK / terbuthylazine (N2-tert-butyl-6-chloro-N4-ethyl-1,3,5-triazine-2,4-diamine) / 227-637-9 / 5915-41-3 / 24/11/2011 / 15/01/2014
24 / PL / chlorsulfuron / 265-268-5 / 64902-72-3 / 10/11/2011 / 31/12/2013
25 / PL / disodium tetraborate pentahydrate / 215-540-4 / 12179-04-3 / 09/11/2011 / 30/12/2015
26 / PL / arsenic / 231-148-6 / 7440-38-2 / 09/11/2011 / 30/12/2015
27 / PL / disodium tetraborate decahydrate / 215-540-4 / 1303-96-4 / 09/11/2011 / 30/12/2015
28 / PL / orthoboric acid / 237-560-2 / 13840-56-7 / 09/11/2011 / 30/12/2014
29 / PL / tetraboron disodium heptaoxide / 235-541-3 / 12267-73-1 / 09/11/2011 / 30/12/2014
30 / PL / disodium tetraborate / 215-540-4 / 1330-43-4 / 09/11/2011 / 30/12/2014
31 / PL / diboron trioxide / 215-125-8 / 1303-86-2 / 09/11/2011 / 30/12/2014
32 / PL / boric acid, crude natural / 234-343-4 / 11113-50-1 / 09/11/2011 / 30/12/2014
33 / DE / cyanamide / 206-992-3 / 420-04-2 / 14/06/2011 / 15/07/2013
34 / UK / netofluthrin / - / 240494-70-6 / 08/06/2011 / 31/01/2014
35 / UK / triadimenol (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol / 259-537-6 / 55219-65-3 / 27/02/2013 / 29/11/2013
36 / DE / IDS, NA-SALZ / 429-200-1 / 144538-83-0 / 11/05/2009 / 2014/2015

Annex II: dossiers in the CLH process (Before RAC Adoption)

Table 2a. dossiers in Accordance Check

No / DS / Substance Name / EC number / CAS number
1 / AT / fenpyrazamine / - / 473798-59-3
2 / NL / clethodim (ISO); 2-[N-{[(2E)-3-chloroprop-2-en-1-yl]oxy}propanimidoyl]-5-[2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one / - / 99129-21-2
3 / UK / pirimicarb (ISO); 5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate / 245-430-1 / 23103-98-2
4 / ES / quinolin-8-ol / 205-711-1 / 148-24-3
5 / NO / 2-Benzyl-4-chlorophenol / 204-385-8 / 120-32-1
6 / FR / carbetamide (ISO); (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate / 240-286-6 / 16118-49-3
7 / SE / dicyclohexyl phthalate / 201-545-9 / 84-61-7
8 / DE / diisobutyl phthalate / 201-553-2 / 84-69-5

Annex II: dossiers in the CLH process (Before RAC Adoption)

Table 2B. dossiers pending public consultation

No / DS / Substance name / EC number / CAS number / Public consultation
1 / DE / reaction mass of bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate and 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane / 406-750-9 / 129757-67-1 / pending
2 / NL / TBHP (Hydroperoxide, 1,1-Dimethylethyl) / 200-915-7 / 75-91-2 / pending
3 / NL / triflumizole ( (E)-4-chloro-α,α,α-trifluoro-N-(1-imidazol-1-yl-2- ) / - / 99387-89-0 / pending
4 / FR / tribasic copper Sulphate / 231-847-6 / 12527-76-3 / pending
5 / FR / copper Oxychloride / 215-572-9 / 1332-40-7 or 1332-65-6 / pending
6 / FR / copper powder / 231-159-6 / 7440-50-8 / pending
7 / FR / copper thiocyanate / 214-183-1 / 1111-67-7 / pending
8 / FR / bordeaux mixture / - / 8011-63-0 / pending
9 / FR / basic copper carbonate / 235-113-6 / 12069-69-1 / pending
10 / FR / copper (II) oxide / 215-269-1 / 1317-38-0 / pending
11 / FR / copper (II) hydroxide / 243-815-9 / 20427-59-2 / pending
12 / FR / copper (I) oxide / 215-270-7 / 1317-39-1 / pending
13 / FR / copper sulphate pentahydrate / 231-847-6 / 7758-98-7 (7758-99-8 and 12527-76-3) / pending
14 / FR / methylmercuric chloride / 204-064-2 / 115-09-3 / pending
15 / ES / acetochlor / 251-899-3 / 34256-82-1 / pending
16 / DE / geranonitril (3,7-dimethylocta-2,6-dienenitrile) / 225-918-0 / 5146-66-7 / pending
17 / IND / 1,2-Dichloropropane / 201-152-2 / 78-87-5 / pending
18 / AT / DCPP; 5-Chloro-2-(4-chlorophenoxy)-phenol / 429-290-0 / 3380-30-1 / Awaiting resubmission
19 / SE / heptadecafluorononanoic acid / 206-801-3 / 375-95-1 / Awaiting resubmission
20 / DE / reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol / 401-680-5 / - / Awaiting resubmission
21 / NL / n,n-dimethylacetamide (DMAC) / 204-826-4 / 127-19-5 / Awaiting resubmission
22 / DE / zinc phosphide / 215-244-5 / 1314-84-7 / Awaiting resubmission
23 / NL / pencycuron (ISO); 1-(4-chlorobenzyl)-1-cyclopentyl-3-phenylurea / 266-096-3 / 66063-05-6 / Awaiting resubmission
24 / SE / linalool / 201-134-4 / 78-70-6 / Awaiting resubmission
25 / UK / bendiocarb (ISO); (2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate) / 245-216-8 / 22781-23-3 / Awaiting resubmission
26 / DE / spiroxamine / - / 118134-30-8 / Awaiting resubmission
27 / UK / iodomethane / 200-819-5 / 74-88-4 / Awaiting resubmission
28 / AT / (Z)-11-hexadecen-1-yl acetate / 251-791-6 / 34010-21-4 / Awaiting resubmission
29 / AT / E/Z-8-dodecenyl acetate / 253-904-4 / 248-823-6 / 38363-29-0 / 28079-04-1 / Awaiting resubmission
30 / PT / chloralose (INN); (R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose; glucochloralose; anhydroglucochloral / 240-016-7 / 15879-93-3 / Awaiting resubmission
31 / IE / silthiofam (4,5-Dimethyl-2-trimethylsilanyl-thiophene-3-carboxylic acid allylamide) / - / 175217-20-6 / Awaiting resubmission
32 / IE / picoxystrobin (Methyl (E)-3-methoxy-2-{2-[6-(trifluoromethyl) -2- pyridyloxymethyl]phenyl} acrylate) / - / 117428-22-5 / Awaiting resubmission
33 / IE / fluquinconazole (3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4(3H)-one) / 411-960-9 / 136426-54-5 / Awaiting resubmission
34 / IE / diphenylamine / 204-539-4 / 122-39-4 / Awaiting resubmission
35 / IE / zineb (Carbamaodithioic acid, 1,2-ethane) / 235-180-1 / 12122-67-7 / Awaiting resubmission
36 / IE / propamocarb (Propyl 3-(dimethylamino) propylcarbamate hydrochloride) / 247-125-9 / 25606-41-1 / Awaiting resubmission
37 / AT / (E)-5-decen-1-yl acetate / 253-923-8 / 38421-90-8 / Awaiting resubmission
38 / AT / (E)-8-dodecen-1-yl acetate / 253-904-4 / 38363-29-0 / Awaiting resubmission
39 / AT / (Z)-8-dodecen-1-yl acetate / 248-823-6 / 28079-04-1 / Awaiting resubmission
40 / AT / (Z)-9-dodecen-1-yl acetate / 241-054-7 / 16974-11-1 / Awaiting resubmission
41 / AT / (E,Z)-7,9-dodecadien-1-yl acetate / 259-127-7 / 54364-62-4 / Awaiting resubmission
42 / AT / (E)-11-tetradecen-1-yl acetate / 251-401-4 / 33189-72-9 / Awaiting resubmission
43 / AT / (Z)-9-tetradecen-1-yl acetate / 240-780-1 / 16725-53-4 / Awaiting resubmission
44 / AT / (Z)-11-tetradecen-1-yl acetate / 243-982-8 / 20711-10-8 / Awaiting resubmission
45 / AT / (Z,E)-9,12-tetradecadien-1-yl acetate / 250-753-6 / 30507-70-1 / Awaiting resubmission
46 / AT / (Z,E)-7,11-hexadecadien-1-yl acetate / - / 51606-94-4 / Awaiting resubmission
47 / AT / (E,Z)-2,13-octadecadien-1-yl acetate / - / 86252-65-5 / Awaiting resubmission
48 / AT / Dodecan-1-yl acetate / 203-995-1 / 112-66-3 / Awaiting resubmission
49 / AT / (E,E)-7,9-dodecadien-1-yl acetate / - / 54364-63-5 / Awaiting resubmission
50 / AT / (Z,Z)-7,11-hexadecadien-1-yl acetate / - / 52207-99-5 / Awaiting resubmission
51 / AT / E-5-decen-1-ol / 260-267-6 / 56578-18-8 / Awaiting resubmission
52 / AT / (Z)-8-dodecenol / 255-019-9 / 40642-40-8 / Awaiting resubmission
53 / AT / (E,E)-8,10-dodecadien-1-ol / 251-761-2 / 33956-49-9 / Awaiting resubmission
54 / AT / 1-tetradecanol / 204-000-3 / 112-72-1 / Awaiting resubmission
55 / AT / (Z)-11-hexadecen-1-ol / 260-337-6 / 56683-54-6 / Awaiting resubmission
56 / AT / (Z)-7-tetradecenal / 265-493-9 / 65128-96-3 / Awaiting resubmission
57 / AT / (Z)-9-hexadecenal / 260-064-2 / 56219-04-6 / Awaiting resubmission
58 / AT / (Z)-11-hexadecenal / 258-876-7 / 53939-28-9 / Awaiting resubmission
59 / AT / (Z)-13-octadecenal / 261-349-4 / 58594-45-9 / Awaiting resubmission
60 / AT / 1,4-Diaminobutane (Putrescine) / 203-782-3 / 110-60-1 / Awaiting resubmission
61 / AT / K-HDO / - / 66603-10-9 / Awaiting resubmission
62 / AT / CU-HDO (Bis(N-cyclohexyl-diazenium-dioxy)-copper) / - / 312600-89-8 / Awaiting resubmission
63 / UK / thiacloprid (ISO); (Z)-N-{3-[(6-Chloro-3-pyridinyl)methyl]-1,3-thiazolan-2-yliden}cyanamide / 111988-49-9 / Awaiting resubmission

Annex II: dossiers in the CLH process (Before RAC Adoption)

Table 2c. Dossiers under public consultation

No / DS / Substance name / EC number / CAS number / Publication for Comments / Deadline for comments / RAC discussion
1 / FI / glutaraldehyde / 203-856-5 / 111-30-8 / 25/09/2013 / 11/11/2013 / Planned RAC discussion at
RAC 28
2 / DE / fluopyram / - / 658066-35-4 / 09/10/2013 / 25/11/2013 / Planned RAC discussion at
RAC 29
3 / IND / 2-(4-tert-butylbenzyl)propionaldehyde / 201-289-8 / 80-54-6 / 29/10/2013 / 13/12/2013 / Planned RAC discussion at RAC 30
4 / IT / methanol / 200-659-6 / 67-56-1 / 29/10/2013 / 13/12/2013 / Planned RAC discussion at RAC 30

Annex II: dossiers in the CLH process (Before RAC Adoption)

Table 2d. RAC opinion development

No / DS / Substance Name / EC number / CAS number / Publication (PC) starting date / RAC Discussion
1 / IND / phenol, dodecyl-, branched [Tetrapropenylphenol (TPP)] / 310-154-3 / 121158-58-5 / 18/12/2012 / First discussion at RAC 26, and to continue at RAC 27
2 / IE / sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide / - / 946578-00-3 / 06/02/2013 / First discussion at RAC 26, and to continue at RAC 27
3 / SE / lead / 231-100-4 / 7439-92-1 / 23/10/2012 / First discussion at RAC26, and to continue at RAC27
4 / IT / brodifacoum (ISO); 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)- 1,2,3,4-tetrahydro-1-naphthyl)coumarin / 259-980-5 / 56073-10-0 / 05/03/2013 / First discussion at RAC26, and to continue at RAC27
5 / NL / flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4- tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4- (4-trifluoromethylbenzyloxy)phenyl)-1- naphthyl)coumarin / 421-960-0 / 90035-08-8 / 05/03/2013 / First discussion at RAC26, and to continue at RAC27
6 / IE / warfarin (ISO); 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one / 201-377-6 / 81-81-2 [racemic mixture] / 05/03/2013 / First discussion at RAC 26, and to continue at RAC27
7 / DK / coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1- naphthyl)coumarin / 227-424-0 / 5836-29-3 / 05/03/2013 / First discussion at RAC 26, and to continue at RAC 28
8 / SE / bromadiolone (ISO); 3-[3-(4'-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one / 249-205-9 / 28772-56-7 / 05/03/2013 / First discussion at RAC 26, and to continue at RAC28
9 / ES / chlorophacinone (ISO); 2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione / 223-003-0 / 3691-35-8 / 05/03/2013 / First discussion at RAC 26, and to continue at RAC 28
10 / NO / difethialone (ISO); 3-[3-(4'-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one / - / 104653-34-1 / 05/03/2013 / First discussion at RAC 26, and to continue at RAC 28
11 / FI / difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1- naphthyl)-4-hydroxycoumarin / 259-978-4 / 56073-07-5 / 05/03/2013 / First discussion at RAC 26, and to continue at RAC 28
12 / IND / phenol, dodecyl-, branched (TPP) / 310-154-3 / 121158-58-5 / 05/03/2013 / Planned first discussion at RAC 27
13 / DE / tributyltin compounds / - / - / 06/06/2013 / Planned first discussion at RAC 27
14 / NL / bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate / 442-820-5 / 149877-41-8 / 26/03/2013 / Planned first discussion at RAC27
15 / BE / lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione / 218-499-0 / 2164-08-1 / 14/05/2013 / Planned first discussion at RAC27
16 / FR / triflusulfuron (ISO); 2-[4-dimethylamino-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-ylcarbamoylsulfamoyl]-m-toluic acid / - / 126535-15-7 / 26/03/2013 / Planned first discussion at RAC 27
17 / DE / fenpyroximate (ISO); tert-butyl 4-[({[(E)-(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate / - / 134098-61-6 / 30/04/2013 / Planned first discussion at RAC-27
18 / FR / bisphenol A; 4,4'-isopropylidenediphenol / 201-245-8 / 80-05-7 / 27/08/2013 / Planned first discussion at RAC 28
19 / PL / chlorobenzene / 203-628-5 / 108-90-7 / 21/08/2013 / Planned first discussion at RAC 28
20 / NL / 1-methyl-2-pyrrolidone (NMP) / 212-828-1 / 872-50-4 / 27/08/2013 / Planned first discussion at RAC 28
21 / CZ / flumioxazin (ISO) / - / 103361-09-7 / 06/09/2013 / Planned first discussion at RAC 28
22 / FR / polyhexamethylene biguanide hydrochloride (PHMB) / - / 27083-27-8 or 32289-58-0 / 06/06/2013 / Planned first discussion at RAC 28
23 / SE / hydroxyisohexyl 3-cyclohexene carboxaldehyde / - / 31906-04-4 / 02/07/2013 / Planned first discussion at RAC 28
24 / NL / bupirimate (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-yl dimethylsulphamate / 255-391-2 / 41483-43-6 / 02/07/2013 / Plan first discussion at RAC 28
25 / DE / Direct Blue FC 57087 / 418-870-9 / 154212-58-5 / 26/03/2013 / Planned first discussion at RAC-28
26 / FR / special purpose E-glass fibres / - / - / 05/03/2013 / Plan first discussion at RAC 28
27 / FR / special purpose 475-glass fibres / - / - / 05/03/2013 / Plan first discussion at RAC 28
28 / NL / disodium octaborate tetrahydrate / 234-541-0 / 12280-03-4 / 30/04/2013 / Planned first discussion at RAC 28 or RAC 29
29 / NL / disodium octaborate anhydrate / 234-541-0 / 12008-41-2 / 30/04/2013 / Planned first discussion at RAC 28 or RAC 29
30 / PL / boric acid / 233-139-2 / 10043-35-3 / 14/05/2013 / Planned first discussion at RAC 28 or RAC 29
31 / NL / propylene oxide / 200-879-2 / 75-56-9 / 06/09/2013 / Planned first discussion at RAC 29

Annex III: Opinions adopted by RAC

Table 3a. Opinions adopted by RAC and their relevant ATP

No / DS / Substance name / EC number / CAS number / Public consultation started / RAC Opinion / ATP published
1 / DE / 1,2-epoxybutane (2-ethyloxirane) / 203-438-2 / 106-88-7 / 06/02/2013 / First discussion and adopted at RAC 26 / planned 7th ATP
2 / IND / imidazole / 206-019-2 / 288-32-4 / 18/12/2012 / First discussion and adopted at RAC 26 / planned 7th ATP
3 / NL / dodemorph acetate / 250-778-2 / 31717-87-0 / 18/12/2012 / First discussion and adopted at RAC 26 / planned 7th ATP
4 / NL / dodemorph / 216-474-9 / 1593-77-7 / 18/12/2012 / First discussion and adopted at RAC 26 / planned 7th ATP
5 / AT / spirotetramat (ISO) / - / 203313-25-1 / 28/09/2012 / First discussed at RAC 25 and adopted at RAC 26 / planned 7th ATP
6 / NL / pyridaben (2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one ) / 405-700-3 / 96489-71-3 / 18/12/2012 / Adopted by written procedure before RAC 26 / planned 7th ATP
7 / SE / diisohexyl phthalate (DIHP) / 271-093-5 / 68515-50-4 / 07/08/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
8 / NL / etridiazole (ethyl-3-trichloromethyl-1,2,4-thiadiazol-5-yl ether) / 219-991-8 / 2593-15-9 / 28/02/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
9 / UK / tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate / 432-770-2 / 139189-30-3 / 14/05/2012 / First discussion and adopted at RAC 23 / planned 6th ATP
10 / DE / nitric acid / 231-714-2 / 7697-37-2 / 21/06/2012 / First discussion and adopted by written procedure before RAC 25 / planned 7th ATP
11 / IND / dioctyltin bis(2-ethylhexyl mercaptoacetate) / 239-622-4 / 15571-58-1 / 25/03/2011 / First discussion at RAC 19 and continued at RAC 20. Adopted by written procedure before RAC 21 / 5th ATP 03/10/2013
12 / FR / dimethyltin dichloride (DMTC) / 212-039-2 / 753-73-1 / 14/02/2012 / First discussion and adopted at RAC 23 / planned 6th ATP
13 / FR / dimethyltin bis(2-ethylhexylmercaptoacetate) (DMT EHMA) / 260-829-0 / 57583-35-4 / 14/02/2012 / First discussion and adopted at RAC 23 / planned 6th ATP
14 / NL / Tebuconazole / 403-640-2 / 107534-96-3 / 21/08/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
15 / FR / flonicamid / - / 158062-67-0 / 21/06/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
16 / NL / carvone / 202-759-5 [1]; 218-827-2 [2]; 229-352-5 [3] / 99-49-0 [1]; 2244-16-8 [2]; 6485-40-1 [3] / 23/10/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
17 / NL / isoxaflutole / - / 141112-29-0 / 14/05/2012 / First discussion and adopted at RAC 24 / planned 7th ATP
18 / AT / fenoxaprop-P-ethyl / - / 71283-80-2 / 17/04/2012 / First discussion and adopted at RAC 24 / planned 7th ATP
19 / DE / 1,1',1''-nitrilotripropan-2-ol (TIPA) / 204-528-4 / 122-20-3 / 03/10/2011 / First discussion and adopted at RAC 20 / 5th ATP 03/10/2013
20 / FR / metosulam / - / 139528-85-1 / 14/05/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
21 / UK / fyrolflex (1-methylethylidene)di-4,1-phenylene tetraphenyl diphosphate / 425-220-8 / 5945-33-5 / 25/11/2011 / First discussion and adopted at RAC 23 / planned 6th ATP
22 / UK / thixatrol Max / 432-430-3 / - / 30/08/2011 / Adopted by written procedure before RAC 21 / 5th ATP 03/10/2013
23 / AT / tembotrione / - / 335104-84-2 / 14/05/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
24 / DE / imazalil / 252-615-0 / 35554-44-0 / 21/08/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
25 / DE / benzoic acid / 200-618-2 / 65-85-0 / 30/08/2011 / First discussion at RAC-20 and continued at RAC 21. Adopted at RAC 23 / planned 6th ATP
26 / AT / fluazinam / - / 79622-59-6 / 20/05/2011 / First discussion at RAC 20 and adopted at RAC 21 / planned 6th ATP
27 / AT / cymoxanil / 261-043-0 / 57966-95-7 / 14/06/2011 / First discussion at RAC 19 and adopted at RAC 22 / planned 6th ATP
28 / AT / mandipropamid / - / 374726-62-2 / 28/02/2012 / First discussion and adopted at RAC 24 / planned 7th ATP
29 / AT / fenpyrazamine / - / 473798-59-3 / 25/01/2012 / First discussion and adopted at RAC 23 / planned 6th ATP
30 / AT / cycloxydim / 405-230-9 / 101205-02-1 / 17/08/2011 / First discussion at RAC 22 and adopted at RAC 23 / planned 6th ATP
31 / AT / amidosulfuron / 407-380-0 / 120923-37-7 / 29/07/2011 / First discussion at RAC 19 and adopted at RAC 20 / 5th ATP 03/10/2013
32 / UK / perestane / 432-790-1 / 847871-03-8 / 25/03/2011 / First discussion and adopted at RAC 17 / 5th ATP 03/10/2013
33 / DE / tebufenpyrad / - / 119168-77-3 / 29/07/2011 / First discussion and adopted at RAC 20 / 5th ATP 03/10/2013
34 / UK / Proquinazid / - / 189278-12-4 / 07/06/2011 / First discussion at RAC 19. Discussed at the first WebEx meeting in Jan 2012 and adopted at RAC-20 / 5th ATP 03/10/2013
35 / NL / ethephon / 240-718-3 / 16672-87-0 / 14/06/2011 / First discussion at RAC 22 and adopted at RAC 23 / planned 6th ATP
36 / DE / dimethenamid-P / - / 163515-14-8 / 23/10/2012 / Adopted at RAC 25 / planned 7th ATP
37 / DE / tricalcium diphosphide / 215-142-0 / 1305-99-3 / 21/06/2012 / Adopted at RAC 24 / planned 7th ATP
38 / DE / methyl 2,5-dichlorobenzoate / 220-815-7 / 2905-69-3 / 17/08/2011 / First discussion at RAC 22 and adopted at RAC 23 / planned 6th ATP
39 / DK / styrene / 202-851-5 / 100-42-5 / 10/10/2011 / First discussion at RAC 21 and adopted at RAC 23 / planned 6th ATP
40 / FR / tetrahydrofurfuryl alcohol (THFA) / 202-625-6 / 97-99-4 / 25/11/2011 / First discussion at RAC 21 and continued at RAC 22. Adopted at RAC 23. / planned 6th ATP
41 / FR / 4 vinylcyclohexene (VCH) / 202-848-9 / 100-40-3 / 30/05/2011 / First discussion at RAC 19 and continued at RAC 20 and RAC 21. Adopted at RAC 22. / planned 6th ATP
42 / FR / dihexyl phthalate / 201-559-5 / 84-75-3 / 17/01/2011 / First discussion at RAC 16 and adopted at RAC 17 / 5th ATP 03/10/2013
43 / FR / n-ethyl-2-pyrrolidone (NEP) (1-ethylpyrrolidin-2-one) / 220-250-6 / 2687-91-4 / 25/03/2011 / First discussion at RAC 17 and continued at RAC 18. Adopted at RAC 19 / 5th ATP 03/10/2013
44 / DE / fenoxycarb / 276-696-7 / 72490-01-8 / 17/08/2011 / First discussion at RAC 21 and adopted at RAC 22 / planned 6th ATP
45 / AT / octanoic acid / 204-677-5 / 124-07-2 / 21/06/2012 / First discussion and adopted at RAC 25 / planned 7th ATP
46 / AT / cis-Tricos-9-ene (muscalure) / 248-505-7 / 27519-02-4 / 25/01/2012 / First discussed and adopted at RAC 23 / planned 6th ATP
47 / AT / etofenprox / 407-980-2 / 80844-07-1 / 25/01/2012 / First discussed and adopted at RAC 23 / Planned 6th ATP
48 / AT / nonanoic acid / 203-931-2 / 112-05-0 / 21/06/2012 / First discussed and adopted at RAC 25 / planned 7th ATP
49 / AT / decanoic acid / 206-376-4 / 334-48-5 / 21/06/2012 / First discussed and adopted at RAC 25 / planned 7th ATP
50 / NO / ammoniumpentadecafluorootanoate (APFO) / 223-320-4 / 3825-26-1 / 07/01/2011 / First discussed at RAC 17 and continued at RAC 18. Adopted at RAC 19 / 5th ATP 03/10/2013
51 / DE / trimagnesium diphosphide / 235-023-7 / 12057-74-8 / 25/03/2011 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013
52 / DK / 3-Iodo-2-propynylbutylcarbamate / 259-627-5 / 55406-53-6 / 29/07/2011 / First discussed at RAC-22 and adopted at RAC 23 / planned 6th ATP
53 / DE / penconazole / 266-275-6 / 66246-88-6 / 17/01/2011 / First discussed at RAC 17 and continued at RAC 18, RAC 19 and RAC 20. Adopted by written procedure after RAC 21 / planned 6th ATP
54 / NL / pitch, coal tar, high temp. / 266-028-2 / 65996-93-2 / 01/10/2010 / First discussed at RAC 16 and continued at RAC 17. Adopted at RAC 18 / 5th ATP 03/10/2013
55 / NL / fenamiphos / 244-848-1 / 22224-92-6 / 19/10/2010 / First discussed at RAC 16 and adopted at RAC 17 / 5th ATP 03/10/2013
56 / DE / vinyl acetate / 203-545-4 / 108-05-4 / 20/08/2010 / First discussed at RAC 15 and adopted at RAC 16 / 5th ATP 03/10/2013
57 / DE / 2,4,4-trimethylpentene / 246-690-9 / 25167-70-8 / 20/08/2010 / First discussed at RAC 15 and adopted at RAC 16 / 5th ATP 03/10/2013
58 / DE / nitrobenzene / 202-716-0 / 98-95-3 / 17/01/2011 / First discussed at RAC 17 and continued at RAC 18. Adopted at RAC 19 / 5th ATP 03/10/2013
59 / DE / 2-ethoxyethanol / 203-804-1 / 110-80-5 / 20/08/2010 / First discussed and adopted at RAC 15 / 3rd ATP 11/07/2012
60 / DE / amines, Tallow Alkyl / 263-125-1 / 61790-33-8 / 19/10/2010 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013
61 / DE / 4-tert-butylbenzoic acid / 202-696-3 / 98-73-7 / 09/07/2010 / First discussed at RAC 14. Adopted by written procedure before RAC 15. / 3rd ATP 11/07/2012
62 / DE / potassium sorbate / 246-376-1 / 24634-61-5 / 14/05/2012 / First discussed and adopted at RAC 24 / planned 7th ATP
63 / NO / p-tert-butylphenol / 202-679-0 / 98-54-4 / 07/01/2011 / First discussed at RAC 17, and continued at RAC 19 and RAC 20. Adopted at RAC 21 / planned 6th ATP
64 / NL / aluminium-magnesium-zinc-carbonate-hydroxide / 423-570-6 / 169314-88-9 / 01/10/2010 / First discussed at RAC 15 and adopted at RAC 16 / 5th ATP 03/10/2013
65 / DE / amines, coco alkyl / 262-977-1 / 61788-46-3 / 19/10/2010 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013
66 / DE / amines, hydrogenated tallow alkyl / 262-976-6 / 61788-45-2 / 19/10/2010 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013
67 / DE / (z)-octadec-9-enylamine / 204-015-5 / 112-90-3 / 19/10/2010 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013
68 / DE / octadecylamine / 204-695-3 / 124-30-1 / 19/10/2010 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013
69 / DE / ethylbenzene / 202-849-4 / 100-41-4 / 17/01/2011 / First discussed at RAC 17 and continued at RAC 18. Adopted by written procedure before RAC 21 / Planned 6th ATP
70 / UK / leucomalachite green / 204-961-9 / 129-73-7 / 21/06/2010 / First discussed at RAC 13 and adopted by written procedure before RAC 14 / 3rd ATP 11/07/2012
71 / NO / perfluorooctanic acid (PFOA) / 206-397-9 / 335-67-1 / 07/01/2011 / First discussed at RAC 17, and continued at RAC 18. Adopted at RAC 19 / 5th ATP 03/10/2013
72 / DE / sulcotrione / - / 99105-77-8 / 17/01/2011 / First discussed at RAC 17 and adopted at RAC 18 / 5th ATP 03/10/2013
73 / DE / aclonifen / 277-704-1 / 74070-46-5 / 17/01/2011 / First discussed and adopted at RAC 17 / 5th ATP 03/10/2013
74 / FR / PHMB (poly(iminoimidocarbonyl)iminohexamethylene hydrochloride) / - / 27083-27-8 or 32289-58-0 / 31/03/2010 / First discussed at RAC 13, and continued at RAC 14, RAC 15 and RAC 16. Adopted by written procedure before RAC 17 / 5th ATP 03/10/2013
75 / FR / flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea / 417-680-3 / 101463-69-8 / 31/03/2010 / First discussed at RAC 13, and continued at RAC 14 and RAC 15. Adopted at RAC 16 / 5th ATP 03/10/2013
76 / FR / bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro- 3,3,3-trifluoroprop-1-en-1-yl]- 2,2-dimethylcyclopropanecarboxylate / - / 82657-04-3 / 22/02/2010 / First discussed at RAC 12 and continued at RAC 15. Adopted by written procedure before RAC 16 / 5th ATP 03/10/2013
77 / NL / acequinocyl (ISO);
3-dodecyl-1,4-dioxo-1,4- dihydronaphthalen-2-yl acetate / - / 57960-19-7 / 22/02/2010 / First discussion and provisional agreement on the classification at RAC 12 and adopted at RAC 13 / 3rd ATP 11/07/2012
78 / NL / abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]
avermectin B1a (purity ≥80 %); [2] / -[1]
265-610-3 [2] / 71751-41-2[1]
65195-55-3 [2] / 10/09/2009 / First discussed at RAC 9 and adopted at RAC 10 / 3rd ATP 11/07/2012
79 / DK / white spirit type 0, Solvent naphtha (petroleum), medium aliphatic / 265-191-7 / 64742-88-7 / 18/01/2010 / First discussed at RAC 12, and continued at RAC 14 and RAC 15. Adopted at RAC 16 / 5th ATP 03/10/2013
80 / DK / white spirit type 1, naphtha (petroleum), hydrodesulphurised heavy / 265-185-4 / 64742-82-1 / 18/01/2010 / First discussed at RAC 12, and continued at RAC 14 and RAC 15. Adopted at RAC 16 / 5th ATP 03/10/2013
81 / DK / stoddard solvent (US term for white spirit, corresponding to white spirit type 1; see CAS-no. 64742-82-1) / 232-489-3 / 8052-41-3 / 18/01/2010 / First discussed at RAC 12, and continued at RAC 14 and RAC 15. Adopted at RAC 16 / 5th ATP 03/10/2013
82 / UK / acrolein / 203-453-4 / 107-02-8 / 29/07/2011 / First discussed and adopted at RAC-21 / 5th ATP 03/10/2013
83 / UK / tralkoxydim / - / 87820-88-0 / 30/08/2011 / First discussed and adopted at RAC-22 / planned 6th ATP
84 / UK / fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole / 223-404-0 / 3878-19-1 / 18/01/2010 / First discussed at RAC 11, and continued at RAC 12. Adopted at RAC 13. / 3rd ATP 11/07/2012
85 / UK / metazachlor / 266-583-0 / 67129-08-2 / 12/03/2010 / First discussed at RAC 13, and continued at RAC 14. Adopted at RAC 15. / 3rd ATP 11/07/2012
86 / UK / indoxacarb and indoxacarb (enantiomeric reaction mass S:R 75:25) / - / 173584-44-6 / 27/08/2010 / First discussed at RAC 15 and adopted by written procedure before RAC 16. / 5th ATP 03/10/2013
87 / NO / 8:2 fluorotelomer alcohol (8:2 FTOH) / 211-648-0 / 678-39-7 / 17/04/2012 / First discussed and adopted at RAC 24 / No C&L
88 / NL / trixylyl phosphate / 246-677-8 / 25155-23-1 / 12/06/2009 / First discussed at RAC 8 and adopted at RAC 9. / 3rd ATP 11/07/2012
89 / SE / epoxiconazole / 406-850-2 / 133855-98-8 / 23/02/2009 / First discussed at RAC 8 and RAC 9. Adopted at RAC 10
90 / SE / Hexabromocyclododecane [1]
1,2,5,6,9,10- hexabromocyclododecane [2] / 247-148-4 [1]
221-695-9 [2] / 25637-99-4[1]
3194-55-6 [2] / 04/11/2009 / Discussed and provisional agreement on the classification at RAC 11. Discussed at RAC 12 and RAC 13. Adopted at RAC 14. / 3rd ATP 11/07/2012
91 / SE / diantimony trioxide / 215-175-0 / 1309-64-4 / 23/02/2009 / First discussed and adopted at RAC 7. / None-no change to current CLP
92 / FR / 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2- oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4- stannatetradecanoate / 260-828-5 / 57583-34-3 / 17/01/2011 / First discussed at RAC 16 and adopted at RAC 17 / 5th ATP 03/10/2013
93 / FR / trichloromethylstannane / 213-608-8 / 993-16-8 / 17/01/2011 / First discussed at RAC 16 and adopted at RAC 17 / 5th ATP 03/10/2013
94 / FR / tetrahydrofuran / 203-726-8 / 109-99-9 / 02/09/2009 / First discussed at RAC 10 and adopted at RAC 11 / 3rd ATP 11/07/2012
95 / FR / indium phosphide / 244-959-5 / 22398-80-0 / 12/06/2009 / First discussed at RAC 8 and adopted at RAC 9 / 3rd ATP 11/07/2012
96 / FR / di-tert-butylperoxide / 203-733-6 / 110-05-4 / 12/06/2009 / First discussed at RAC 8 and adopted at RAC 9 / 3rd ATP 11/07/2012
97 / FR / gallium arsenide / 215-114-8 / 1303-00-0 / 12/06/2009 / First discussed at RAC 8, and continued at RAC 10. Adopted at RAC 11 / 5th ATP 03/10/2013 (excl. reprotoxicity)
98 / FR / formaldehyde / 200-001-8 / 50-00-0 / 31/10/2011 / First discussed at RAC 22 and adopted at RAC 23 / planned 6th ATP
99 / FR / TNPP (tris(nonylphenyl)phosphite) / 247-759-6 / 26523-78-4 / 22/02/2010 / First discussed at RAC 12 and adopted at RAC 13 / 3rd ATP 11/07/2012
100 / FR / chloroform / 200-663-8 / 67-66-3 / 30/04/2010 / First discussed at RAC 13, and continued at RAC 14 and RAC 15. Adopted at RAC 16 / 5th ATP 03/10/2013
101 / IE / TDCP (Tris[2-chloro-1-(chloromethyl)ethyl] phosphate) / 237-159-2 / 13674-87-8 / 02/09/2009 / First discussed at RAC 10,a nd continued at RAC 11. Adopted by written procedure before RAC 12 / 3rd ATP 11/07/2012
102 / DE / diphenyl(2,4,6- trimethylbenzoyl)phosphine oxide / 278-355-8 / 75980-60-8 / 30/03/2010 / First discussed and adopted at RAC 13 / 3rd ATP 11/07/2012
103 / DE / trisodium hexafluroaluminate [1]
trisodium hexafluoroaluminate (cryolite) [2] / 237-410-6 [1]
239-148-8 [2] / 13775-53-6[1]
15096-52-3[2] / 04/11/2009 / First discussed and adopted at RAC 11 / 3rd ATP 11/07/2012
104 / DE / aluminium phosphide / 244-088-0 / 20859-73-8 / 25/03/2011 / First discussed at RAC 18 and adopted at RAC 19 / 5th ATP 03/10/2013

Annex III: Opinions adopted by RAC